Cases
CourtFilingsPetition dateMore filters
Case closed Jun 30, 2021
Sancilio Pharmaceuticals is now proceeding under a liquidation plan that became effective on May 31, 2019, following a Chapter 11 case initiated to preserve value while the business pursued asset sales and an orderly wind-down.
Updated Sep 5, 2:24 AM ET
Notice of Change of Address Notice of Change of Firm Address Filed by Oracle America, Inc.. (Christianson, Shawn)
Dkt. 470 · Oct 4, 2022
Notice of Satisfaction of Claim Third Notice of Satisfaction of Claims. Filed by Faegre Drinker Biddle & Reath LLP. (Attachments: # (1) Exhibit A) (Marasco, Jaclyn)
Dkt. 469 · Jul 22, 2022
Chapter 11 Post-Confirmation Report for the Quarter Ending: 12/31/2021 Sancilio Pharmaceuticals Company, Inc. [18-11333] Filed by Faegre Drinker Biddle & Reath LLP. (Marasco, Jaclyn)
Dkt. 468 · Feb 25, 2022
Use with MCP to query this case from your own tools.
Record as of September 6, 2026. Docket entries and dates come from the court. Nothing on this page is AI-generated.